ESC 365 - Prognostic implications of atrial fibrillation in young patients without overt heart disease - an early marker of future cardiomyopathy ?

Back

ESC Professional Premium Access

Prognostic implications of atrial fibrillation in young patients without overt heart disease - an early marker of future cardiomyopathy ?

Session: Atrial fibrillation and heart failure: a deadly combination

Topic: Heart Failure in Atrial Fibrillation

Speaker: Doctor P. Rasmussen (Copenhagen, DK)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Peter Vibe Rasmussen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

0 follower

4 more presentations in this session

Integrating pre- and post-ablation B-type natriuretic peptide to identify high-risk population for long-term adverse events and arrhythmic recurrence in persistent atrial fibrillation

Speaker: Doctor S. Hashimoto (Ube, JP)

Tachycardiomyopathy is associated with metabolic changes that predict LVEF recovery - results from the EMPATHY study

Speaker: Doctor D. Heinzmann (Tuebingen, DE)

ECG changes predict new-onset heart failure in patients with atrial fibrillation.

Speaker: Doctor C. Binding (Copenhagen, DK)

Care and outcomes of atrial fibrillation in potentially vulnerable populations: A 20-year perspective using real-world data

Speaker: Doctor N. Nouhravesh (Durham, US)

Access the full session

Atrial fibrillation and heart failure: a deadly combination

Speakers: Doctor P. Rasmussen, Doctor S. Hashimoto, Doctor D. Heinzmann, Doctor C. Binding, Doctor N. Nouhravesh

Access

Video

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources